1
|
Dong T, Zhang Z, Li W, Zhuo W, Cui T, Li Z. Synthesis Principle and Practice with Radioactive Iodines and Astatine: Advances Made So Far. J Org Chem 2024; 89:11837-11863. [PMID: 39173032 DOI: 10.1021/acs.joc.4c00593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/24/2024]
Abstract
Radioactive iodines and astatine, possessing distinct exploitable nuclear properties, play indispensable roles in the realms of nuclear imaging and therapy. Their analogous chemical characteristics shape the design, preparation, and substrate range for tracers labeled with these radiohalogens through interconnected radiosynthetic chemistry. This perspective systematically explores the labeling methods by types of halogenating reagents─nucleophilic and electrophilic─underpinning the rational design of such compounds. It delves into the rapidly evolving synthetic strategies and reactions in radioiodination and radioastatination over the past decade, comparing their intrinsic relationships and highlighting variations. This comparative analysis illuminates potential radiosynthetic methods for exploration. Moreover, stability concerns related to compounds labeled with radioactive iodines and astatine are addressed, offering valuable insights for radiochemists and physicians alike.
Collapse
Affiliation(s)
- Taotao Dong
- State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integrations in Vaccine Research, Xiamen University, Xiamen, Fujian 361102, China
| | - Zhenru Zhang
- State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integrations in Vaccine Research, Xiamen University, Xiamen, Fujian 361102, China
| | - Weicai Li
- State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integrations in Vaccine Research, Xiamen University, Xiamen, Fujian 361102, China
| | - Weibin Zhuo
- Alpha Nuclide Co., Ltd., Ningbo, Zhejiang 315336, China
| | - Tongjiang Cui
- Alpha Nuclide Co., Ltd., Ningbo, Zhejiang 315336, China
| | - Zijing Li
- State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integrations in Vaccine Research, Xiamen University, Xiamen, Fujian 361102, China
| |
Collapse
|
2
|
Gao J, Li M, Yin J, Liu M, Wang H, Du J, Li J. The Different Strategies for the Radiolabeling of [ 211At]-Astatinated Radiopharmaceuticals. Pharmaceutics 2024; 16:738. [PMID: 38931860 PMCID: PMC11206656 DOI: 10.3390/pharmaceutics16060738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2024] [Revised: 05/10/2024] [Accepted: 05/22/2024] [Indexed: 06/28/2024] Open
Abstract
Astatine-211 (211At) has emerged as a promising radionuclide for targeted alpha therapy of cancer by virtue of its favorable nuclear properties. However, the limited in vivo stability of 211At-labeled radiopharmaceuticals remains a major challenge. This review provides a comprehensive overview of the current strategies for 211At radiolabeling, including nucleophilic and electrophilic substitution reactions, as well as the recent advances in the development of novel bifunctional coupling agents and labeling approaches to enhance the stability of 211At-labeled compounds. The preclinical and clinical applications of 211At-labeled radiopharmaceuticals, including small molecules, peptides, and antibodies, are also discussed. Looking forward, the identification of new molecular targets, the optimization of 211At production and quality control methods, and the continued evaluation of 211At-labeled radiopharmaceuticals in preclinical and clinical settings will be the key to realizing the full potential of 211At-based targeted alpha therapy. With the growing interest and investment in this field, 211At-labeled radiopharmaceuticals are poised to play an increasingly important role in future cancer treatment.
Collapse
Affiliation(s)
- Jie Gao
- China Institute for Radiation Protection, National Atomic Energy Agency Nuclear Technology (Nonclinical Evaluation of Radiopharmaceuticals) Research and Development Center, CNNC Key Laboratory on Radiotoxicology and Radiopharmaceutical Preclinical Evaluation, Taiyuan 030006, China; (J.G.); (M.L.); (J.Y.); (M.L.)
- China Institute of Atomic Energy, Beijing 102413, China;
| | - Mei Li
- China Institute for Radiation Protection, National Atomic Energy Agency Nuclear Technology (Nonclinical Evaluation of Radiopharmaceuticals) Research and Development Center, CNNC Key Laboratory on Radiotoxicology and Radiopharmaceutical Preclinical Evaluation, Taiyuan 030006, China; (J.G.); (M.L.); (J.Y.); (M.L.)
| | - Jingjing Yin
- China Institute for Radiation Protection, National Atomic Energy Agency Nuclear Technology (Nonclinical Evaluation of Radiopharmaceuticals) Research and Development Center, CNNC Key Laboratory on Radiotoxicology and Radiopharmaceutical Preclinical Evaluation, Taiyuan 030006, China; (J.G.); (M.L.); (J.Y.); (M.L.)
| | - Mengya Liu
- China Institute for Radiation Protection, National Atomic Energy Agency Nuclear Technology (Nonclinical Evaluation of Radiopharmaceuticals) Research and Development Center, CNNC Key Laboratory on Radiotoxicology and Radiopharmaceutical Preclinical Evaluation, Taiyuan 030006, China; (J.G.); (M.L.); (J.Y.); (M.L.)
- China Institute of Atomic Energy, Beijing 102413, China;
| | - Hongliang Wang
- First Hospital of Shanxi Medical University, Taiyuan 030001, China;
| | - Jin Du
- China Institute of Atomic Energy, Beijing 102413, China;
- China Isotope & Radiation Corporation, Beijing 100089, China
| | - Jianguo Li
- China Institute for Radiation Protection, National Atomic Energy Agency Nuclear Technology (Nonclinical Evaluation of Radiopharmaceuticals) Research and Development Center, CNNC Key Laboratory on Radiotoxicology and Radiopharmaceutical Preclinical Evaluation, Taiyuan 030006, China; (J.G.); (M.L.); (J.Y.); (M.L.)
| |
Collapse
|
3
|
Yssartier T, Liu L, Pardoue S, Le Questel JY, Guérard F, Montavon G, Galland N. In vivo stability of 211At-radiopharmaceuticals: on the impact of halogen bond formation. RSC Med Chem 2024; 15:223-233. [PMID: 38283213 PMCID: PMC10809332 DOI: 10.1039/d3md00579h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Accepted: 11/22/2023] [Indexed: 01/30/2024] Open
Abstract
211At, when coupled to a targeting agent, is one of the most promising radionuclides for therapeutic applications. The main labelling approach consists in the formation of astatoaryl compounds, which often show a lack of in vivo stability. The hypothesis that halogen bond (XB) interactions with protein functional groups initiate a deastatination mechanism is investigated through radiochemical experiments and DFT modelling. Several descriptors agree on the known mechanism of iodoaryl substrates dehalogenation by iodothyronine deiodinases, supporting the higher in vivo dehalogenation of N-succinimidyl 3-[211At]astatobenzoate (SAB) conjugates in comparison with their iodinated counterparts. The guanidinium group in 3-[211At]astato-4-guanidinomethylbenzoate (SAGMB) prevents the formation of At-mediated XBs with the selenocysteine active site in iodothyronine deiodinases. The initial step of At-aryl bond dissociation is inhibited, elucidating the better in vivo stability of SAGMB conjugates compared with those of SAB. The impact of astatine's ability to form XB interactions on radiopharmaceutical degradation may not be limited to the case of aryl radiolabeling.
Collapse
Affiliation(s)
- Thibault Yssartier
- CNRS, CEISAM UMR 6230, Nantes Université F-44000 Nantes France
- CNRS, SUBATECH UMR 6457, IMT Atlantique F-44307 Nantes France
| | - Lu Liu
- CNRS, IPHC UMR 7178, Université de Strasbourg F-67037 Strasbourg France
| | - Sylvain Pardoue
- CNRS, SUBATECH UMR 6457, IMT Atlantique F-44307 Nantes France
| | | | - François Guérard
- Inserm UMR 1307, CNRS UMR 6075, CRCI2NA, Nantes Université, Université d'Angers F-44000 Nantes France
| | - Gilles Montavon
- CNRS, SUBATECH UMR 6457, IMT Atlantique F-44307 Nantes France
| | - Nicolas Galland
- CNRS, CEISAM UMR 6230, Nantes Université F-44000 Nantes France
| |
Collapse
|
4
|
Sasaki I, Tada M, Liu Z, Tatsuta M, Okura T, Aoki M, Takahashi K, Ishioka NS, Watanabe S, Tanaka H. 1-( N, N-Dialkylcarbamoyl)-1,1-difluoromethanesulfonyl ester as a stable and effective precursor for a neopentyl labeling group with astatine-211. Org Biomol Chem 2023; 21:7467-7472. [PMID: 37670575 DOI: 10.1039/d3ob00944k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/07/2023]
Abstract
Radiohalogens with a short half-life are useful radioisotopes for radiotheranostics. Astatine-211 is an α-emitting radiohalogen and is expected to be applicable to targeted α therapy. A neopentyl labeling group is an effective hydrophilic labeling unit for various radiohalogens, which includes 211At. In this study, a 1-(N,N-dialkylcarbamoyl)-1,1-difluoromethanesulfonyl (CDf) ester was developed as a stable precursor for labeling with 211At, 77Br and 125I through a neopentyl labeling group. The CDf ester remained stable in an acetonitrile solution at room temperature and enabled the successful syntheses of 211At-labeled compounds in a highly radiochemical conversion in the presence of K2CO3. 77Br- and 125I-labeled compounds can be prepared from the CDf ester without a base. The utility of the CDf ester was demonstrated in the synthesis of a benzylguanidine with a neopentyl 211At-labeling group. The developed method afforded a 32% radiochemical yield of 211At-labeled benzylguanidine. However, a partial deastatination was observed under acidic conditions during the removal of an N-Boc protecting group. Deprotecting these groups under milder acidic conditions may improve the radiochemical yield. In conclusion, the CDf ester facilitates the syntheses of 211At, 125I and 77Br-labeled compounds that use a neopentyl labeling group for radiotheranostic applications. Further optimization of protecting groups and reaction conditions should enhance the total radiochemical yield of the 211At-labeled compounds.
Collapse
Affiliation(s)
- Ichiro Sasaki
- Department of Quantum-Applied Biosciences, Takasaki Institute for Advanced Quantum Science National Institutes for Quantum Science and Technology, 1233 Watanuki-machi, Takasaki, Gunma 370-1292, Japan
| | - Masatoshi Tada
- Department of Chemical Science and Engineering, Tokyo Institute of Technology, 12-12-1-H101 Ookayama, Meguro, Tokyo, 152-8552, Japan.
| | - Ziyun Liu
- Department of Chemical Science and Engineering, Tokyo Institute of Technology, 12-12-1-H101 Ookayama, Meguro, Tokyo, 152-8552, Japan.
| | - Maho Tatsuta
- Department of Chemical Science and Engineering, Tokyo Institute of Technology, 12-12-1-H101 Ookayama, Meguro, Tokyo, 152-8552, Japan.
| | - Takeru Okura
- Department of Chemical Science and Engineering, Tokyo Institute of Technology, 12-12-1-H101 Ookayama, Meguro, Tokyo, 152-8552, Japan.
| | - Miho Aoki
- Advanced Clinical Research Center, Fukushima Global Medical Science Center, Fukushima Medical University, 1 Hikariga-oka, Fukushima, Fukushima 960-1295, Japan
| | - Kazuhiro Takahashi
- Advanced Clinical Research Center, Fukushima Global Medical Science Center, Fukushima Medical University, 1 Hikariga-oka, Fukushima, Fukushima 960-1295, Japan
| | - Noriko S Ishioka
- Department of Quantum-Applied Biosciences, Takasaki Institute for Advanced Quantum Science National Institutes for Quantum Science and Technology, 1233 Watanuki-machi, Takasaki, Gunma 370-1292, Japan
| | - Shigeki Watanabe
- Department of Quantum-Applied Biosciences, Takasaki Institute for Advanced Quantum Science National Institutes for Quantum Science and Technology, 1233 Watanuki-machi, Takasaki, Gunma 370-1292, Japan
| | - Hiroshi Tanaka
- Department of Chemical Science and Engineering, Tokyo Institute of Technology, 12-12-1-H101 Ookayama, Meguro, Tokyo, 152-8552, Japan.
| |
Collapse
|
5
|
Ode Y, Pradipta AR, Ahmadi P, Ishiwata A, Nakamura A, Egawa Y, Kusakari Y, Muguruma K, Wang Y, Yin X, Sato N, Haba H, Tanaka K. Therapeutic efficacy of 211At-radiolabeled 2,6-diisopropylphenyl azide in mouse models of human lung cancer. Chem Sci 2023; 14:8054-8060. [PMID: 37538829 PMCID: PMC10395307 DOI: 10.1039/d3sc02513f] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Accepted: 05/26/2023] [Indexed: 08/05/2023] Open
Abstract
Targeted α-particle therapy (TAT) is an attractive alternative to conventional therapy for cancer treatment. Among the available radionuclides considered for TAT, astatine-211 (211At) attached to a cancer-targeting molecule appears very promising. Previously, we demonstrated that aryl azide derivatives could react selectively with the endogenous acrolein generated by cancer cells to give a diazo compound, which subsequently forms a covalent bond with the organelle of cancer cells in vivo. Herein, we synthesized 211At-radiolabeled 2,6-diisopropylphenyl azide (ADIPA), an α-emitting molecule that can selectively target the acrolein of cancer cells, and investigated its antitumor effect. Our results demonstrate that a single intratumor or intravenous administration of this simple α-emitting molecule to the A549 (human lung cancer) cell-bearing xenograft mouse model, at a low dose (70 kBq), could suppress tumor growth without inducing adverse effects. Furthermore, because acrolein is generally overproduced by most cancer cells, we believe ADIPA is a simple TAT compound that deserves further investigation for application in animal models and humans with various cancer types and stages.
Collapse
Affiliation(s)
- Yudai Ode
- Department of Chemical Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology 2-12-1 Ookayama Meguro Tokyo 152-8552 Japan
| | - Ambara R Pradipta
- Department of Chemical Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology 2-12-1 Ookayama Meguro Tokyo 152-8552 Japan
| | - Peni Ahmadi
- Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan
| | - Akihiro Ishiwata
- Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan
| | - Akiko Nakamura
- Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan
| | - Yasuko Egawa
- Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan
| | - Yuriko Kusakari
- Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan
| | - Kyohei Muguruma
- Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan
| | - Yang Wang
- Nuclear Chemistry Research Team, RIKEN Nishina Center for Accelerator-Based Science 2-1 Hirosawa, Wako Saitama 351-0198 Japan
| | - Xiaojie Yin
- Nuclear Chemistry Research Team, RIKEN Nishina Center for Accelerator-Based Science 2-1 Hirosawa, Wako Saitama 351-0198 Japan
| | - Nozomi Sato
- Nuclear Chemistry Research Team, RIKEN Nishina Center for Accelerator-Based Science 2-1 Hirosawa, Wako Saitama 351-0198 Japan
| | - Hiromitsu Haba
- Nuclear Chemistry Research Team, RIKEN Nishina Center for Accelerator-Based Science 2-1 Hirosawa, Wako Saitama 351-0198 Japan
| | - Katsunori Tanaka
- Department of Chemical Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology 2-12-1 Ookayama Meguro Tokyo 152-8552 Japan
- Biofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research, RIKEN 2-1 Hirosawa, Wako Saitama 351-0198 Japan
| |
Collapse
|
6
|
Petrov SA, Yusubov MS, Beloglazkina EK, Nenajdenko VG. Synthesis of Radioiodinated Compounds. Classical Approaches and Achievements of Recent Years. Int J Mol Sci 2022; 23:13789. [PMID: 36430267 PMCID: PMC9698107 DOI: 10.3390/ijms232213789] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2022] [Revised: 10/30/2022] [Accepted: 11/07/2022] [Indexed: 11/11/2022] Open
Abstract
This review demonstrates the progress in the synthesis of radioiodinated compounds over the past decade. The possibilities and limitations of radiopharmaceuticals with different iodine isotopes, as well as the synthesis of low and high molecular weight compounds containing radioiodine, are discussed. An analysis of synthesis strategies, substrate frameworks, isolation methods, and metabolic stability, and the possibility of industrial production of radioiodinated organic derivatives which can find applications in the synthesis of drugs and diagnostics are presented.
Collapse
Affiliation(s)
- Stanislav A. Petrov
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia
| | - Mekhman S. Yusubov
- Research School of Chemistry and Applied Biomedical Sciences, The Tomsk Polytechnic University, 634050 Tomsk, Russia
| | - Elena K. Beloglazkina
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia
| | - Valentine G. Nenajdenko
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russia
| |
Collapse
|
7
|
Radiolabeling chemistry with heavy halogens iodine and astatine. Nucl Med Mol Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00013-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
8
|
Maingueneau C, Berdal M, Eychenne R, Gaschet J, Chérel M, Gestin JF, Guérard F. 211At and 125I-labeling of (hetero)aryliodonium ylides: astatine wins again. Chemistry 2021; 28:e202104169. [PMID: 34965315 DOI: 10.1002/chem.202104169] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2021] [Indexed: 11/09/2022]
Abstract
Despite the growing interest in radioiodine and 211 At-labeled radiopharmaceuticals, the search for radiolabeling reactions has been somewhat neglected, resulting in a limited number of available radiosynthetic strategies. Herein we report a comparative study of nucleophilic 125 I and 211 At-labeling of aryliodonium ylides. Whereas radioiodination efficiency was low, 211 At-labeling performed efficiently on a broad scope of precursors. The most activated aryliodonium ylides led rapidly to quantitative reactions at room temperature in acetonitrile. For deactivated precursors, heating up to 90°C in glyme and addition of 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) as radical scavenger appeared essential to avoid precursor degradation and to achieve high radiochemical yields and molar activity. The approach was applied successfully to the preparation of 4-[ 211 At]astatophenylalanine (4-APA), an amino acid derivative increasingly studied as radiotherapeutic drug for cancers. This validated aryliodonium ylides as a valuable tool for nucleophilic 211 At-labeling and will complement the short but now growing list of available astatination reactions.
Collapse
Affiliation(s)
- Clémence Maingueneau
- CRCINA: ERL Centre de Cancerologie et d'Immunologie Nantes-Angers, team 13, 8 Quai Moncousu,, 44007, Nantes, FRANCE
| | | | | | | | | | | | | |
Collapse
|
9
|
Guérard F, Maingueneau C, Liu L, Eychenne R, Gestin JF, Montavon G, Galland N. Advances in the Chemistry of Astatine and Implications for the Development of Radiopharmaceuticals. Acc Chem Res 2021; 54:3264-3275. [PMID: 34350753 DOI: 10.1021/acs.accounts.1c00327] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
ConspectusAstatine (At) is the rarest on Earth of all naturally occurring elements, situated below iodine in the periodic table. While only short-lived isotopes (t1/2 ≤ 8.1 h) are known, 211At is the object of growing attention due to its emission of high-energy alpha particles. Such radiation is highly efficient to eradicate disseminated tumors, provided that the radionuclide is attached to a cancer-targeting molecule. The interest in applications of 211At in nuclear medicine translates into the increasing number of cyclotrons able to produce it. Yet, many challenges related to the minute amounts of available astatine are to be overcome in order to characterize its physical and chemical properties. This point is of paramount importance to develop synthetic strategies and solve the labeling instability in current approaches that limits the use of 211At-labeled radiopharmaceuticals. Despite its discovery in the 1940s, only the past decade has seen a significant rise in the understanding of astatine's basic chemical and radiochemical properties, thanks to the development of new analytical and computational tools.In this Account, we give a concise summary of recent advances in the determination of the physicochemical properties of astatine, putting in perspective the duality of this element which exhibits the characteristics both of a halogen and of a metal. Striking features were evidenced in the recent determination of its Pourbaix diagram such as the identification of stable cationic species, At+ and AtO+, contrasting with other halogens. Like metals, these species were shown to form complexes with anionic ligands and to exhibit a particular affinity for organic species bearing soft donor atoms. On the other hand, astatine shares many characteristics with other halogen elements. For instance, the At- species exists in water, but with the least range of EH-pH stability in the halogen series. Astatine can form molecular interactions through halogen bonding, and it was only recently identified as the strongest halogen-bond donor. This ability is nonetheless affected by relativistic effects, which translate to other peculiarities for this heavy element. For instance, the spin-orbit coupling boosts astatine's propensity to form charge-shift bonds, catching up with the behavior of the lightest halogens (fluorine, chlorine).All these new data have an impact on the development of radiolabeling strategies to turn 211At into radiopharmaceuticals. Inspired by the chemistry of iodine, the chemical approaches have sparsely evolved over the past decades and have long been limited to electrophilic halodemetalation reactions to form astatoaryl compounds. Conversely, recent developments have favored the use of the more stable At- species including the aromatic nucleophilic substitution with diaryliodonium salts or the copper-catalyzed halodeboronation of arylboron precursors. However, it is clear that new bonding modalities are necessary to improve the in vivo stability of 211At-labeled aryl compounds. The tools and data gathered over the past decade will contribute to instigate original strategies for overcoming the challenges offered by this enigmatic element. Alternatives to the C-At bond such as the B-At and the metal-At bonds are typical examples of exciting new axes of research.
Collapse
Affiliation(s)
- François Guérard
- Université de Nantes, CNRS, Inserm, CRCINA, F-44000 Nantes, France
| | | | - Lu Liu
- IMT-Atlantique Bretagne-Pays de la Loire - Nantes Campus, SUBATECH, UMR CNRS 6457, F-44000 Nantes, France
| | - Romain Eychenne
- Université de Nantes, CNRS, Inserm, CRCINA, F-44000 Nantes, France
- Arronax GIP, F-44817 Saint-Herblain, France
| | | | - Gilles Montavon
- IMT-Atlantique Bretagne-Pays de la Loire - Nantes Campus, SUBATECH, UMR CNRS 6457, F-44000 Nantes, France
| | - Nicolas Galland
- Université de Nantes, CNRS, CEISAM UMR 6230, F-44000 Nantes, France
| |
Collapse
|
10
|
Matsuoka K, Obata H, Nagatsu K, Kojima M, Yoshino T, Ogawa M, Matsunaga S. Transition-metal-free nucleophilic 211At-astatination of spirocyclic aryliodonium ylides. Org Biomol Chem 2021; 19:5525-5528. [PMID: 34124736 DOI: 10.1039/d1ob00789k] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
The transition-metal-free 211At-astatination of spirocyclic aryliodonium ylides via a nucleophilic aromatic substitution reaction is described. This method enables the preparation of 211At-radiolabeled compounds derived from multi-functionalized molecules and heteroarenes in good to excellent radiochemical yields.
Collapse
Affiliation(s)
- Keitaro Matsuoka
- Faculty of Pharmaceutical Science, Hokkaido University, Sapporo 060-0812, Japan.
| | - Honoka Obata
- Faculty of Pharmaceutical Science, Hokkaido University, Sapporo 060-0812, Japan. and Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, Chiba, 263-8555, Japan
| | - Kotaro Nagatsu
- Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, Chiba, 263-8555, Japan
| | - Masahiro Kojima
- Faculty of Pharmaceutical Science, Hokkaido University, Sapporo 060-0812, Japan.
| | - Tatsuhiko Yoshino
- Faculty of Pharmaceutical Science, Hokkaido University, Sapporo 060-0812, Japan.
| | - Mikako Ogawa
- Faculty of Pharmaceutical Science, Hokkaido University, Sapporo 060-0812, Japan. and Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Sapporo 060-0812, Japan
| | - Shigeki Matsunaga
- Faculty of Pharmaceutical Science, Hokkaido University, Sapporo 060-0812, Japan. and Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Sapporo 060-0812, Japan
| |
Collapse
|
11
|
Eychenne R, Chérel M, Haddad F, Guérard F, Gestin JF. Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight". Pharmaceutics 2021; 13:pharmaceutics13060906. [PMID: 34207408 PMCID: PMC8234975 DOI: 10.3390/pharmaceutics13060906] [Citation(s) in RCA: 74] [Impact Index Per Article: 24.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Revised: 06/02/2021] [Accepted: 06/08/2021] [Indexed: 12/11/2022] Open
Abstract
Among all existing radionuclides, only a few are of interest for therapeutic applications and more specifically for targeted alpha therapy (TAT). From this selection, actinium-225, astatine-211, bismuth-212, bismuth-213, lead-212, radium-223, terbium-149 and thorium-227 are considered as the most suitable. Despite common general features, they all have their own physical characteristics that make them singular and so promising for TAT. These radionuclides were largely studied over the last two decades, leading to a better knowledge of their production process and chemical behavior, allowing for an increasing number of biological evaluations. The aim of this review is to summarize the main properties of these eight chosen radionuclides. An overview from their availability to the resulting clinical studies, by way of chemical design and preclinical studies is discussed.
Collapse
Affiliation(s)
- Romain Eychenne
- Groupement d’Intérêt Public ARRONAX, 1 Rue Aronnax, F-44817 Saint-Herblain, France;
- Université de Nantes, Inserm, CNRS, Centre de Recherche en Cancérologie et Immunologie Nantes—Angers (CRCINA)—UMR 1232, ERL 6001, F-44000 Nantes, France; (M.C.); (F.G.)
- Correspondence: (R.E.); (J.-F.G.)
| | - Michel Chérel
- Université de Nantes, Inserm, CNRS, Centre de Recherche en Cancérologie et Immunologie Nantes—Angers (CRCINA)—UMR 1232, ERL 6001, F-44000 Nantes, France; (M.C.); (F.G.)
| | - Férid Haddad
- Groupement d’Intérêt Public ARRONAX, 1 Rue Aronnax, F-44817 Saint-Herblain, France;
- Laboratoire Subatech, UMR 6457, Université de Nantes, IMT Atlantique, CNRS, Subatech, F-44000 Nantes, France
| | - François Guérard
- Université de Nantes, Inserm, CNRS, Centre de Recherche en Cancérologie et Immunologie Nantes—Angers (CRCINA)—UMR 1232, ERL 6001, F-44000 Nantes, France; (M.C.); (F.G.)
| | - Jean-François Gestin
- Université de Nantes, Inserm, CNRS, Centre de Recherche en Cancérologie et Immunologie Nantes—Angers (CRCINA)—UMR 1232, ERL 6001, F-44000 Nantes, France; (M.C.); (F.G.)
- Correspondence: (R.E.); (J.-F.G.)
| |
Collapse
|
12
|
Berdal M, Gouard S, Eychenne R, Marionneau-Lambot S, Croyal M, Faivre-Chauvet A, Chérel M, Gaschet J, Gestin JF, Guérard F. Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies. Chem Sci 2020; 12:1458-1468. [PMID: 34163909 PMCID: PMC8179031 DOI: 10.1039/d0sc05191h] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Easy access to radioiodinated and 211At-labelled bio(macro)molecules is essential to develop new strategies in nuclear imaging and targeted radionuclide therapy of cancers. Yet, the labelling of complex molecules with heavy radiohalogens is often poorly effective due to the multiple steps and intermediate purifications needed. Herein, we investigate the potential of arylboron chemistry as an alternative approach for the late stage labelling of antibodies. The reactivity of a model precursor, 4-chlorobenzeneboronic acid (1) with nucleophilic iodine-125 and astatine-211 was at first investigated in aqueous conditions. In the presence of a copper(ii) catalyst and 1,10-phenanthroline, quantitative radiochemical yields (RCYs) were achieved within 30 minutes at room temperature. The optimum conditions were then applied to a CD138 targeting monoclonal antibody (mAb) that has previously been validated for imaging and therapy in a preclinical model of multiple myeloma. RCYs remained high (>80% for 125I-labelling and >95% for 211At-labelling), and the whole procedure led to increased specific activities within less time in comparison with previously reported methods. Biodistribution study in mice indicated that targeting properties of the radiolabelled mAb were well preserved, leading to a high tumour uptake in a CD138 expressing tumour model. The possibility of divergent synthesis from a common modified carrier protein demonstrated herein opens facilitated perspectives in radiotheranostic applications with the radioiodine/211At pairs. Overall, the possibility to develop radiolabelling kits offered by this procedure should facilitate its translation to clinical applications. The high reactivity of astatine and iodine in water with arylboronic acids provides access to an efficient single-step antibody radiolabelling.![]()
Collapse
Affiliation(s)
- Marion Berdal
- Université de Nantes, CNRS, Inserm, CRCINA F-44000 Nantes France
| | - Sébastien Gouard
- Université de Nantes, CNRS, Inserm, CRCINA F-44000 Nantes France
| | - Romain Eychenne
- Université de Nantes, CNRS, Inserm, CRCINA F-44000 Nantes France .,Arronax GIP Saint-Herblain France
| | - Séverine Marionneau-Lambot
- Université de Nantes, CNRS, Inserm, CRCINA F-44000 Nantes France .,Department of Nuclear Medicine, CHU Nantes Nantes France
| | - Mikaël Croyal
- CRNH-O, Mass Spectrometry Core Facility F-44000 Nantes France.,NUN, INRA, CHU Nantes, UMR 1280, PhAN, IMAD, CRNH-O F-44000 Nantes France
| | - Alain Faivre-Chauvet
- Université de Nantes, CNRS, Inserm, CRCINA F-44000 Nantes France .,Department of Nuclear Medicine, CHU Nantes Nantes France
| | - Michel Chérel
- Université de Nantes, CNRS, Inserm, CRCINA F-44000 Nantes France .,ICO-René Gauducheau Saint-Herblain France
| | - Joëlle Gaschet
- Université de Nantes, CNRS, Inserm, CRCINA F-44000 Nantes France
| | | | - François Guérard
- Université de Nantes, CNRS, Inserm, CRCINA F-44000 Nantes France
| |
Collapse
|
13
|
Dubost E, McErlain H, Babin V, Sutherland A, Cailly T. Recent Advances in Synthetic Methods for Radioiodination. J Org Chem 2020; 85:8300-8310. [PMID: 32369696 DOI: 10.1021/acs.joc.0c00644] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Organic compounds bearing radioisotopes of iodine are widely used for biological research, diagnostic imaging, and radiotherapy. Early reported synthetic methods for the incorporation of radioiodine have generally involved high temperature reactions or strongly oxidizing conditions. To overcome these limitations and to cope with the demand for novel radioiodinated probes, there has been a surge in the development of new synthetic methodology for radioiodination. This synopsis describes the key transformations developed recently.
Collapse
Affiliation(s)
- Emmanuelle Dubost
- Normandie Univ, UNICAEN, Centre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), 14000 Caen, France
| | - Holly McErlain
- WestCHEM, School of Chemistry, The Joseph Black Building, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - Victor Babin
- Normandie Univ, UNICAEN, Centre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), 14000 Caen, France
| | - Andrew Sutherland
- WestCHEM, School of Chemistry, The Joseph Black Building, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - Thomas Cailly
- Normandie Univ, UNICAEN, Centre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), 14000 Caen, France.,Normandie Univ, UNICAEN, IMOGERE, 14000 Caen, France.,Department of Nuclear Medicine, CHU Côte de Nacre, 14000 Caen, France
| |
Collapse
|
14
|
Woen DH, Eiroa-Lledo C, Akin AC, Anderson NH, Bennett KT, Birnbaum ER, Blake AV, Brugh M, Dalodière E, Dorman EF, Ferrier MG, Hamlin DK, Kozimor SA, Li Y, Lilley LM, Mocko V, Thiemann SL, Wilbur DS, White FD. A Solid-State Support for Separating Astatine-211 from Bismuth. Inorg Chem 2020; 59:6137-6146. [PMID: 32302134 DOI: 10.1021/acs.inorgchem.0c00221] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Increasing access to the short-lived α-emitting radionuclide astatine-211 (211At) has the potential to advance targeted α-therapeutic treatment of disease and to solve challenges facing the medical community. For example, there are numerous technical needs associated with advancing the use of 211At in targeted α-therapy, e.g., improving 211At chelates, developing more effective 211At targeting, and characterizing in vivo 211At behavior. There is an insufficient understanding of astatine chemistry to support these efforts. The chemistry of astatine is one of the least developed of all elements on the periodic table, owing to its limited supply and short half-life. Increasing access to 211At could help address these issues and advance understanding of 211At chemistry in general. We contribute here an extraction chromatographic processing method that simplifies 211At production in terms of purification. It utilizes the commercially available Pre-Filter resin to rapidly (<1.5 h) isolate 211At from irradiated bismuth targets (Bi decontamination factors ≥876 000), in reasonable yield (68-55%) and in a form that is compatible for subsequent in vivo study. We are excited about the potential of this procedure to address 211At supply and processing/purification problems.
Collapse
Affiliation(s)
- David H Woen
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | | | - Andrew C Akin
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | | | - Kevin T Bennett
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | - Eva R Birnbaum
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | - Anastasia V Blake
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | - Mark Brugh
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | - Elodie Dalodière
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | - Eric F Dorman
- Department of Radiation Oncology, University of Washington, Seattle, Washington 98195, United States
| | - Maryline G Ferrier
- Department of Radiation Oncology, University of Washington, Seattle, Washington 98195, United States
| | - Donald K Hamlin
- Department of Radiation Oncology, University of Washington, Seattle, Washington 98195, United States
| | - Stosh A Kozimor
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | - Yawen Li
- Department of Radiation Oncology, University of Washington, Seattle, Washington 98195, United States
| | - Laura M Lilley
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | - Veronika Mocko
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | - Sara L Thiemann
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | - D Scott Wilbur
- Department of Radiation Oncology, University of Washington, Seattle, Washington 98195, United States
| | - Frankie D White
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| |
Collapse
|
15
|
Rossi E, De Santis M, Sorbelli D, Storchi L, Belpassi L, Belanzoni P. Spin-orbit coupling is the key to unraveling intriguing features of the halogen bond involving astatine. Phys Chem Chem Phys 2020; 22:1897-1910. [PMID: 31912075 DOI: 10.1039/c9cp06293a] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
The effect of spin-orbit coupling (SOC) on the halogen bond involving astatine has been investigated using state-of-the-art two- and four-component relativistic calculations. Adducts between Cl-X (X = Cl, Br, I and At) and ammonia have been selected to establish a trend on going down the periodic table. The SOC influence has been explored not only on the geometric and energetic features that can be used to characterize the halogen bond strength but also on the three main contributions to it that are the charge transfer, the "σ-hole" (i.e. the localized region with a net positive electrostatic potential at the halogen site) and the "polar flattening" (which is related to the effective shape of the halogen site). A surprisingly large increase of the Cl-At dipole moment, due to the inclusion of SOC, has been worked out using four-component CCSD(T) reference calculations, indicating that this bond is significantly more ionic than one may predict. Due to the SOC effect, which induces a peculiar charge accumulation on the At side in the Cl-At dimer, a weakening of the astatine-mediated halogen bond occurs arising from the (i) reduced amount of charge transfer, (ii) decrease of the polar flattening and (iii) lowering of the short-range Coulomb potential. The analysis of the electronic structure of the Cl-At moiety allows for a rationalization of the SOC effects on all the considered features of the halogen bond, including an unprecedented unsymmetrical charge back-donation from Cl-At to ammonia.
Collapse
Affiliation(s)
- Elisa Rossi
- Department of Chemistry, Biology and Biotechnology, University of Perugia, via Elce di Sotto 8, 06123 Perugia, Italy.
| | - Matteo De Santis
- Department of Chemistry, Biology and Biotechnology, University of Perugia, via Elce di Sotto 8, 06123 Perugia, Italy.
| | - Diego Sorbelli
- Department of Chemistry, Biology and Biotechnology, University of Perugia, via Elce di Sotto 8, 06123 Perugia, Italy.
| | - Loriano Storchi
- CNR Institute of Chemical Science and Technologies "Giulio Natta" (CNR-SCITEC), via Elce di Sotto 8, 06123 Perugia, Italy. and Dipartimento di Farmacia, Università G. D'Annunzio, via dei Vestini 31, 66100 Chieti, Italy
| | - Leonardo Belpassi
- CNR Institute of Chemical Science and Technologies "Giulio Natta" (CNR-SCITEC), via Elce di Sotto 8, 06123 Perugia, Italy. and Consortium for Computational Molecular and Materials Sciences (CMS)2, via Elce di Sotto 8, 06123 Perugia, Italy
| | - Paola Belanzoni
- Department of Chemistry, Biology and Biotechnology, University of Perugia, via Elce di Sotto 8, 06123 Perugia, Italy. and CNR Institute of Chemical Science and Technologies "Giulio Natta" (CNR-SCITEC), via Elce di Sotto 8, 06123 Perugia, Italy. and Consortium for Computational Molecular and Materials Sciences (CMS)2, via Elce di Sotto 8, 06123 Perugia, Italy
| |
Collapse
|
16
|
Kwon YD, Son J, Chun JH. Chemoselective Radiosyntheses of Electron-Rich [18F]Fluoroarenes from Aryl(2,4,6-trimethoxyphenyl)iodonium Tosylates. J Org Chem 2019; 84:3678-3686. [DOI: 10.1021/acs.joc.9b00019] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Affiliation(s)
- Young-Do Kwon
- Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
| | - Jeongmin Son
- Department of Nuclear Medicine, Severance Hospital, Yonsei University Health System, Seoul 03722, Republic of Korea
| | - Joong-Hyun Chun
- Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
| |
Collapse
|
17
|
Navarro L, Berdal M, Chérel M, Pecorari F, Gestin JF, Guérard F. Prosthetic groups for radioiodination and astatination of peptides and proteins: A comparative study of five potential bioorthogonal labeling strategies. Bioorg Med Chem 2018; 27:167-174. [PMID: 30529152 DOI: 10.1016/j.bmc.2018.11.034] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2018] [Revised: 11/22/2018] [Accepted: 11/24/2018] [Indexed: 02/06/2023]
Abstract
125I- and 211At-labeled azide and tetrazine based prosthetic groups for bioorthogonal conjugation were designed and tested in a comparative study of five bioorthogonal systems. All five bioconjugation reactions conducted on a model clickable peptide led to quantitative yields within less than a minute to several hours depending on the system used. Transferability to the labeling of an IgG was demonstrated with one of the bioorthogonal system. This study provides several new alternatives to the conventional and suboptimal approach currently in use for radioiodination and astatination of biomolecules and should accelerate the development of new probes with these radionuclides for applications in nuclear imaging and targeted alpha-therapy.
Collapse
Affiliation(s)
- Laurent Navarro
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France
| | - Marion Berdal
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France
| | - Michel Chérel
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France
| | - Frédéric Pecorari
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France
| | - Jean-François Gestin
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
| | - François Guérard
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
| |
Collapse
|
18
|
Molina B, Soto JR, Castro JJ. Halogen-like properties of the Al 13 cluster mimicking astatine. Phys Chem Chem Phys 2018; 20:11549-11553. [PMID: 29651478 DOI: 10.1039/c8cp00494c] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Astatine-211 is considered to be one of the most promising alpha-emitters in targeted alpha therapy (TAT). However, its development has been hindered by its not so well understood chemistry. Hence, any attempt to understanding it better is imperative. Here, we show through DFT calculations that the neutral endohedral Al13 cluster follows a reactivity pattern very similar to At, more than any other halogen. The halogen and alkali bonding with Al13 and At presented a strong similarity in their charge transfer processes. Moreover, upon the interchange of At with Al13, we found a stable configuration of the compound corresponding to the astatination of aryliodonium salts, which have been considered as possible precursors for the synthesis of 211At-labeled tracers. Our results provide promising proof of concept that the Al13 cluster mimics the behaviour of At and might help in better understanding its chemistry and in streamlining the chemical processes of radiolabeling biomolecules.
Collapse
Affiliation(s)
- B Molina
- Departamento de Física, Facultad de Ciencias, Universidad Nacional Autónoma de México, Apdo. Post. 70-646, 04510, Ciudad de México, Mexico.
| | | | | |
Collapse
|
19
|
Reilly SW, Makvandi M, Xu K, Mach RH. Rapid Cu-Catalyzed [ 211At]Astatination and [ 125I]Iodination of Boronic Esters at Room Temperature. Org Lett 2018; 20:1752-1755. [PMID: 29561158 PMCID: PMC5973503 DOI: 10.1021/acs.orglett.8b00232] [Citation(s) in RCA: 56] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
Access to 211At- and 125I-radiolabeled compounds in excellent RCCs and RCYs was achieved in just 10 min at room temperature using a Cu catalyst. The reaction conditions are applicable to a broad class of aryl and heteroaryl boronic reagents with varying steric and electronic properties as well as late-stage astatination and iodination of anticancer PARP inhibitors. This protocol eliminates the traditional need for toxic organotin reagents, elevated temperatures, and extended reaction times, providing a more practical and environmentally friendly approach to developing α-emitting radiotherapeutics.
Collapse
Affiliation(s)
- Sean W. Reilly
- Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - Mehran Makvandi
- Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - Kuiying Xu
- Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - Robert H. Mach
- Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| |
Collapse
|
20
|
Experimental and computational evidence of halogen bonds involving astatine. Nat Chem 2018; 10:428-434. [PMID: 29556053 DOI: 10.1038/s41557-018-0011-1] [Citation(s) in RCA: 51] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2017] [Accepted: 01/18/2018] [Indexed: 01/04/2023]
Abstract
The importance of halogen bonds-highly directional interactions between an electron-deficient σ-hole moiety in a halogenated compound and an acceptor such as a Lewis base-is being increasingly recognized in a wide variety of fields from biomedicinal chemistry to materials science. The heaviest halogens are known to form stronger halogen bonds, implying that if this trend continues down the periodic table, astatine should exhibit the highest halogen-bond donating ability. This may be mitigated, however, by the relativistic effects undergone by heavy elements, as illustrated by the metallic character of astatine. Here, the occurrence of halogen-bonding interactions involving astatine is experimentally evidenced. The complexation constants of astatine monoiodide with a series of organic ligands in cyclohexane solution were derived from distribution coefficient measurements and supported by relativistic quantum mechanical calculations. Taken together, the results show that astatine indeed behaves as a halogen-bond donor-a stronger one than iodine-owing to its much more electrophilic σ-hole.
Collapse
|
21
|
Meyer GJ. Astatine. J Labelled Comp Radiopharm 2018; 61:154-164. [PMID: 29080397 DOI: 10.1002/jlcr.3573] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2017] [Revised: 09/14/2017] [Accepted: 09/29/2017] [Indexed: 12/20/2022]
Abstract
This educational review describes and summarizes the historic discovery of element 85, the experiments leading to its physical and chemical characterization and comparison with its lighter homologue iodine. The half-lives of its longest living isotopes 210 At and 211 At with 8.3 and 7.22 hours respectively together with their alpha decay characteristics made these isotopes interesting for radiation biological research. However, the lack of stable isotopes of astatine presents a strong challenge for all characterizations. Nevertheless, the decay characteristics especially of 211 At stimulated several research groups to develop labelling strategies for the preparation of astatinated radiopharmaceuticals for targeted alpha radiation therapy. Because of the distinct differences in the chemical behaviour of astatine, when compared with iodine, these approaches are quite challenging. Accordingly, quite different labelling strategies have been tested, namely nucleophilic and electrophilic substitution reactions as well as complex forming strategies. Classic and new developments for the preparation of these compounds are reviewed.
Collapse
Affiliation(s)
- Geerd-J Meyer
- Klinik für Nuklearmedizin/Radiopharmazeutische Chemie, Medizinische Hochschule Hannover, Hannover, Germany
| |
Collapse
|
22
|
Masumoto Y, Miyamoto K, Iuchi T, Ochiai M, Hirano K, Saito T, Wang C, Uchiyama M. Mechanistic Study on Aryl-Exchange Reaction of Diaryl-λ 3-iodane with Aryl Iodide. J Org Chem 2018; 83:289-295. [PMID: 29183123 DOI: 10.1021/acs.joc.7b02701] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Because of its hyper-leaving ability, as well as its strong oxidizing ability, diaryl(triflato)-λ3-iodane transfers one of the aryl groups to iodoarenes simply upon gentle heating (>85 °C) in nonpolar solvents. We have performed an in-depth mechanistic study of this unusual aryl transfer reaction. A combination of experimental (product analysis, kinetic study, and substituent effects) and density functional theoretical approaches revealed that the reaction proceeds through a concerted bimolecular transition state, in which ipso-carbon binds loosely to both iodine centers. We also evaluated electronic effects on the thermodynamic stability of diaryl-λ3-iodanes.
Collapse
Affiliation(s)
- Yui Masumoto
- Graduate School of Pharmaceutical Sciences, The University of Tokyo , 7-3-1 Hongo Bunkyo-ku, Tokyo 113-0033, Japan.,Elements Chemistry Laboratory, RIKEN, and Advanced Elements Chemistry Research Team, RIKEN Center for Sustainable Resource Science (CSRS) , Wako-shi, Saitama 351-0198, Japan
| | - Kazunori Miyamoto
- Graduate School of Pharmaceutical Sciences, The University of Tokyo , 7-3-1 Hongo Bunkyo-ku, Tokyo 113-0033, Japan
| | - Takuto Iuchi
- Graduate School of Pharmaceutical Sciences, Tokushima University , 1-78 Shomachi, Tokushima 770-8505, Japan
| | - Masahito Ochiai
- Graduate School of Pharmaceutical Sciences, Tokushima University , 1-78 Shomachi, Tokushima 770-8505, Japan
| | - Keiichi Hirano
- Graduate School of Pharmaceutical Sciences, The University of Tokyo , 7-3-1 Hongo Bunkyo-ku, Tokyo 113-0033, Japan
| | - Tatsuo Saito
- Graduate School of Pharmaceutical Sciences, The University of Tokyo , 7-3-1 Hongo Bunkyo-ku, Tokyo 113-0033, Japan
| | - Chao Wang
- Graduate School of Pharmaceutical Sciences, The University of Tokyo , 7-3-1 Hongo Bunkyo-ku, Tokyo 113-0033, Japan
| | - Masanobu Uchiyama
- Graduate School of Pharmaceutical Sciences, The University of Tokyo , 7-3-1 Hongo Bunkyo-ku, Tokyo 113-0033, Japan.,Elements Chemistry Laboratory, RIKEN, and Advanced Elements Chemistry Research Team, RIKEN Center for Sustainable Resource Science (CSRS) , Wako-shi, Saitama 351-0198, Japan
| |
Collapse
|
23
|
Altomonte S, Telu S, Lu S, Pike VW. Pd(0)-Mediated 11C-Carbonylation of Aryl(mesityl)iodonium Salts as a Route to [ 11C]Arylcarboxylic Acids and Derivatives. J Org Chem 2017; 82:11925-11932. [PMID: 28972758 DOI: 10.1021/acs.joc.7b01704] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Pd(0)-mediated 11C-carbonylation of aryl(mesityl)iodonium salts followed by suitable quench provides a rapid room-temperature two-pot procedure for labeling arylcarboxylic acids and amide derivatives with the short-lived positron emitter carbon-11 (t1/2 = 20.4 min) in generally good to high yields (up to 71%). High product ring selectivity (≥13) was achieved when using mesityl as a spectator group in the diaryliodonium salt precursors. This process has potential for preparing new radiotracers for molecular imaging with positron emission tomography.
Collapse
Affiliation(s)
- Stefano Altomonte
- Molecular Imaging Branch, NIMH, National Institutes of Health , Bethesda, Maryland 20892, United States
| | - Sanjay Telu
- Molecular Imaging Branch, NIMH, National Institutes of Health , Bethesda, Maryland 20892, United States
| | - Shuiyu Lu
- Molecular Imaging Branch, NIMH, National Institutes of Health , Bethesda, Maryland 20892, United States
| | - Victor W Pike
- Molecular Imaging Branch, NIMH, National Institutes of Health , Bethesda, Maryland 20892, United States
| |
Collapse
|
24
|
Guérard F, Navarro L, Lee YS, Roumesy A, Alliot C, Chérel M, Brechbiel MW, Gestin JF. Bifunctional aryliodonium salts for highly efficient radioiodination and astatination of antibodies. Bioorg Med Chem 2017; 25:5975-5980. [PMID: 28964629 DOI: 10.1016/j.bmc.2017.09.022] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2017] [Revised: 09/12/2017] [Accepted: 09/17/2017] [Indexed: 02/06/2023]
Abstract
In this report we describe the development of an alternative approach to arylstannane chemistry for radiolabeling antibodies with radioiodine or astatine based on aryliodonium salts precursors. Bifunctional aryliodonium salts were designed and tested for the synthesis of 125I and 211At labeled prosthetic groups for bioconjugation. The nature of the electron rich aryl group was varied and its impact on the regioselectivity of radiohalogenation was evaluated. Unexpectedly, whereas the 2-thienyl group provided the best regioselectivity towards the radioiodination of the aryl moiety of interest (98:2), it was less selective for astatination (87:13); the anisyl group providing the best regioselectivity of astatination (94:6). Under optimized conditions, both radioiodination and astatination could be performed very efficiently in mild conditions (radiochemical yields>85%). The ionic nature of the precursors was exploited to develop an efficient purification approach: the HPLC step that is usually necessary in conventionnal approaches to optimize removal of organotin toxic precursors and side products was replaced by a filtration through a silica cartridge with a significantly reduced loss of radiolabeled product. The purified radioiodinated and astatinated prosthetic groups were then conjugated efficiently to an anti-CD138 monoclonal antibody (75-80% conjugation yield). By using this novel and simple radiohalogenation procedure, higher overall radiochemical yields of astatination were obtained in comparison with the use of an arylstannane precursor and procedures of the litterature for labeling the same antibody. Overall, due to their simplicity of use and high robustness, these new precursors should simplify the labeling of proteins of interest with iodine and astatine radioisotopes for imaging and therapeutic applications.
Collapse
Affiliation(s)
- F Guérard
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
| | - L Navarro
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France
| | - Y-S Lee
- Center for Molecular Modeling, Office of Intramural Research, Center for Information Technology, National Institutes of Health, Bethesda, MD 20892, USA
| | - A Roumesy
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France
| | - C Alliot
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France; GIP ARRONAX, 1 rue Aronnax, CS 10112, 44817 Saint-Herblain Cedex, France
| | - M Chérel
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France
| | - M W Brechbiel
- Radioimmune & Inorganic Chemistry Section, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
| | - J-F Gestin
- CRCINA, Inserm, CNRS, Université d'Angers, Université de Nantes, Nantes, France
| |
Collapse
|
25
|
Zhou D, Kim SH, Chu W, Voller T, Katzenellenbogen JA. Evaluation of aromatic radiobromination by nucleophilic substitution using diaryliodonium salt precursors. J Labelled Comp Radiopharm 2017; 60:450-456. [PMID: 28512784 DOI: 10.1002/jlcr.3519] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2017] [Revised: 05/05/2017] [Accepted: 05/08/2017] [Indexed: 01/20/2023]
Abstract
Radiobromine-labeled compounds can be used for positron emission tomography (PET) imaging (ie, 76 Br) and for radiation therapy (ie, 77 Br). However, the commonly used electrophilic substitution reaction using no-carrier-added radiobromide does not always afford the desired product due to the high reactivity of the brominating intermediate. A nucleophilic substitution by bromide, such as radiobromination of iodonium precursors, provides an alternative route for the synthesis of bromo-radiopharmaceuticals. The applicability of aromatic radiobromination by nucleophilic substitution using diaryliodonium salt precursors was evaluated using iodonium model compounds and [76 Br]/[77 Br]bromide. Radiobromination was observed under all conditions tested, in up to quantitative yields. A QMA cartridge treatment method and a base-free method have been developed, and no extra base is needed for either methods. The base-free conditions are mild and afford much cleaner reactions. Up to 20% water is tolerated in the reactions without reducing the radiochemical yields. No-carrier-added and carrier-added reactions afforded similar results. 4-Bromobenzaldehyde and 4-bromobenzoate have been radiosynthesized reliably and in good yields. These results indicate that this method is robust and efficient and thus will provide a route for radiobromination of electron-deficient arenes and an alternative route for the synthesis of bromo-radiopharmaceuticals for biological evaluations.
Collapse
Affiliation(s)
- Dong Zhou
- Department of Radiology, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA
| | - Sung Hoon Kim
- Department of Chemistry, University of Illinois at Urbana-Champaign, Champaign, IL, USA
| | - Wenhua Chu
- Department of Radiology, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA
| | - Thomas Voller
- Department of Radiology, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA
| | | |
Collapse
|
26
|
Lee YS, Chun JH, Hodošček M, Pike VW. Crystal Structures of Diaryliodonium Fluorides and Their Implications for Fluorination Mechanisms. Chemistry 2017; 23:4353-4363. [PMID: 28145069 PMCID: PMC5687088 DOI: 10.1002/chem.201604803] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2016] [Revised: 12/22/2016] [Indexed: 12/30/2022]
Abstract
The radiofluorination of diaryliodonium salts is of value for producing radiotracers for positron emission tomography. We report crystal structures for two diaryliodonium fluorides. Whereas diphenyliodonium fluoride (1 a) exists as a tetramer bridged by four fluoride ions, 2-methylphenyl(phenyl)iodonium fluoride (2 a) forms a fluoride-bridged dimer that is further halogen bonded to two other monomers. We discuss the topological relationships between the two and their implications for fluorination in solution. Both radiofluorination and NMR spectroscopy show that thermolysis of 2 a gives 2-fluorotoluene and fluorobenzene in a 2 to 1 ratio that is in good agreement with the ratio observed from the radiofluorination of 2-methylphenyl(phenyl)iodonium chloride (2 b). The constancy of the product ratio affirms that the fluorinations occur via the same two rapidly interconverting transition states whose energy difference dictates chemoselectivity. From quantum chemical studies with density functional theory we attribute the "ortho-effect" to the favorable electrostatic interaction between the incoming fluoride and the o-methyl in the transition state. By utilizing the crystal structures of 1 a and 2 a, the mechanisms of fluoroarene formation from diaryliodonium fluorides in their monomeric, homodimeric, heterodimeric, and tetrameric states were also investigated. We propose that oligomerization energy dictates whether the fluorination occurs through a monomeric or an oligomeric pathway.
Collapse
Affiliation(s)
- Yong-Sok Lee
- Center for Molecular Modeling, Office of Intramural Research, Center for Information Technology, National Institutes of Health, Building 12A, Rm 2049, Bethesda, MD, 20892, USA
| | - Joong-Hyun Chun
- Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Rm. B3C346A, 10 Center Drive, Bethesda, MD, 20892, USA
- Present address: Department of Nuclear Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, South Korea
| | - Milan Hodošček
- National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA
- National Institute of Chemistry, Ljubljana, Slovenia
| | - Victor W Pike
- Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Rm. B3C346A, 10 Center Drive, Bethesda, MD, 20892, USA
| |
Collapse
|